Back to mobile site

Rigel Pharma (RIGL) Tops Q3 EPS by 146c

November 4, 2025 4:34 PM EST

Rigel Pharma (NASDAQ: RIGL) reported Q3 EPS of $1.46. Revenue for the quarter came in at $69.46 million.

For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK